Biofibrat

Biofibrat is a medication containing Fenofibrate Micronised, used for managing cholesterol levels and supporting cardiovascular health. This oral medication is manufactured by Biofarm Sp. Z O.O. in the EU.

Biofibrat is primarily used to lower cholesterol levels in the blood, particularly to reduce triglycerides and increase HDL (good cholesterol). It is often prescribed for individuals with high cholesterol or certain types of high blood fat conditions. The medication works by helping the body break down fats more effectively, which can support overall cardiovascular health.

Common effects of Biofibrat may include improvements in cholesterol levels, particularly a reduction in triglycerides and an increase in HDL cholesterol. Some users may experience gastrointestinal discomfort, muscle pain, or headaches. These effects can vary from person to person.

Biofibrat should be used with caution in individuals with liver or kidney problems, as well as those with gallbladder issues. It is important to follow the advice of a healthcare professional regarding its use. Regular monitoring of liver function may be recommended during treatment.

Biofibrat may interact with certain medications, including blood thinners, other cholesterol-lowering drugs, and some antibiotics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated while using this medication.